By Rebecca Melvin
New York, Sept. 12 - Sequenom Inc. priced an upsized $110 million of five-year convertible bonds after the market close on Tuesday at par to yield 5% with an initial conversion premium of 27.5%, according to a news release.
The Rule 144A deal was initially talked at $100 million in size.
Pricing came at the midpoint of talk, which was for a yield of 4.75% to 5.25% and an initial conversion premium of 25% to 30%.
The deal, which was sold via bookrunners J.P. Morgan Securities LLC and Jefferies & Co., has a $20 million greenshoe.
Proceeds of the offering will be used to fund the commercialization of a laboratory-developed test, as well as for other general corporate purposes, including research and development, capital expenditures, working capital and general administrative expenses.
The notes are non-callable for three years and then provisionally callable at a price hurdle of 140%. There are no puts. There is also takeover and dividend protection.
If Sequenom calls the notes, a make-whole fundamental change will be deemed to have occurred and the conversion rate for holders who convert may be increased.
Upon a fundamental change, holders may require Sequenom to repurchase some or all of their convertibles at par plus interest.
San Diego-based Sequenom provides genetic analysis products used in biomedical research, molecular medicine and agricultural applications.
Issuer: | Sequenom Inc.
|
Issue: | Convertible senior notes
|
Amount: | $110 million, upsized from $100 million
|
Greenshoe: | $20 million
|
Maturity: | Oct. 1, 2017
|
Bookrunners: | J.P. Morgan Securities LLC, Jefferies & Co.
|
Coupon: | 5%
|
Price: | Par, $1,000
|
Yield: | 5%
|
Initial conversion premium: | 27.5%
|
Initial conversion price: | $4.63
|
Conversion ratio: | 216.0644 shares
|
Calls: | Non-callable until Oct. 1, 2015, then provisionally callable at 140% price hurdle
|
Puts: | No puts
|
Distribution: | Rule 144A
|
Price talk: | 4.75%-5.25%, up 25%-30%
|
Pricing date: | Sept. 11
|
Settlement date: | Sept. 17
|
Stock symbol: | Nasdaq: SQNM
|
Stock price: | $3.63, as of close Sept. 11
|
Market capitalization: | $430.5 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.